Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Peer Review channel feed
Just like starting over: Moderna tees up another CFO; Geoffrey Porges puts down his SVB pen to join Schrödinger
3 years ago
As Covid program advances, Enanta's new CMO says it's not 'limited to antivirals'; With all eyes on Gilead-partnered cancer drugs, Arcus brings medical chief on board
3 years ago
Astellas taps seasoned CMO amid shift to oncology; Doug Manion steps into a new Arena following $6.7B buyout
3 years ago
Former eGenesis CEO joins vTv as it tries to make a comeback; Eisai nabs Alzheimer’s commercial exec amid lecanemab push
3 years ago
Ex-Moderna commercial leader lands at Celsion as CEO; Schwan song: Changing of the guard at Roche to take effect next year
3 years ago
Former Spark exec to lead a gene therapy upstart of his own; Big Pharma marketing vet named CEO of Swiss biotech
3 years ago
Entos lures former Plexxikon CEO to guide push toward the clinic; Ex-Bristol Myers immunology chief finds new home
4 years ago
Swatting away a takeover attempt, Zymeworks keeps retooling staff; After Cygnal-ing her exit from Flagship, Pearl Huang starts afresh
4 years ago
After seven months of searching, Landos hires a CEO; Marty Duvall re-emerges from ill-fated Oncopeptides tenure
4 years ago
As lawsuit carries on against Guardant Health, CFO shakeup hits Illumina; Pfizer-backed biotech taps CEO to lead pursuit of gene therapy 2.0
4 years ago
Amarin fishes for another CFO as downsizing takes hold; CureVac makes a deal, then lines up Novartis exec to lead development
4 years ago
Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino’s CEO gig
4 years ago
Always chasing the newest science, Schond Greenway joins MindMed; Mirati fills key vacancy with ex-Arena finance chief
4 years ago
Ex-Takeda exec hits the ground running at the helm of rare disease biotech — with 3 priorities off the bat; Seasoned CEO jumps to ALS upstart
4 years ago
Hello, I must be going: Jorge Gomez is Moderna CFO for only a day; As setbacks mount, Inovio’s Joseph Kim chooses the exit ramp
4 years ago
With Aduhelm in tatters, the search is on for Michel Vounatsos' replacement at Biogen; David Liu, Roger Perlmutter join insitro's SAB
4 years ago
‘Natural evolution’: Carisma’s scientific co-founder moves into the CSO post; Vas Narasimhan enlists Ronny Gal to help with Novartis revamp
4 years ago
Moving on from Usama Malik's insider trading imbroglio, Fore resets at the top; Takeda spinout turns to Neurana CEO to lead the way
4 years ago
Let’s build something together: Ex-Lowe’s CFO to join Pfizer while Moderna’s David Meline retires; The CEO-partner party rolls on at Flagship
4 years ago
Xenotransplant gene editor eGenesis snags transplant expert as CMO; John Tsai, Susanne Schaffert among the hard cuts made at Novartis
4 years ago
Changes in high-ranking execs poised to deepen at Karyopharm; Tillman Gerngross-chaired biotech promotes new medical chief to CEO
4 years ago
Roger Perlmutter lures Roy Baynes away from Merck; Now, Voyager: Al Sandrock becomes a CEO after break from Biogen
4 years ago
Zai Lab gives Josh Smiley a second chance in a prime role; Denali gets ready to rearrange staff as clinical hold continues
4 years ago
Centessa gives Antoine Yver a new role, brings his old colleague on board; Prelude to a change: Jane Huang sets up her next move
4 years ago
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page